Upon recommendation by underwriters’ counsel, members of CRA’s accounting and advisory team assisted a US-based bio-technology company in advance of its IPO by advising on existing compliance procedures, tightening financial controls, and enhancing internal reporting, governance, and risk management functions. CRA team members recommended and implemented both qualitative and systems-based solutions designed to address regulatory requirements.
How PE firms can prepare for the DOJ’s Section 8 crackdown on interlocking directorates across portfolio companies
In this article, published in Private Equity Law Report, CRA consultants discuss the renewed push by the US Department of Justice (DOJ) and the Federal Trade...